3D DCE-MRI影像组学预测乳腺恶性病变
本研究基于1.5T乳腺DCE-MRI手动标注的111例患者数据,提取107个影像组学特征,采用UDFS结合SVM构建预测模型,在盲法测试集上鉴别乳腺良恶性病变的AUROC为0.725±0.091,敏感度0.709±0.176,特异度0.741±0.114。
要点
- 仅使用DCE-MRI最强强化期图像即可构建影像组学模型,减少预处理需求。
- 模型在盲法测试集上AUROC为0.725,特异度0.741,敏感度0.709。
- UDFS特征选择联合SVM在测试集上平均性能最佳。
局限性
- 单中心小样本研究,模型性能需外部验证。
- 仅使用最强强化期图像,可能遗漏动态信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop and validate a radiomic model, with radiomic features extracted from breast Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) from a 1.5T scanner, for predicting the malignancy of masses with enhancement. Images were acquired using an 8-channel breast coil in the axial plane. The rationale behind this study is to show the feasibility of a radiomics-powered model that could be integrated into the clinical practice by exploiting only standard-of-care DCE-MRI with the goal of reducing the required image pre-processing (ie, normalization and quantitative imaging map generation).
MATERIALS AND METHODS: 107 radiomic features were extracted from a manually annotated dataset of 111 patients, which was split into discovery and test sets. A feature calibration and pre-processing step was performed to find only robust non-redundant features. An in-depth discovery analysis was performed to define a predictive model: for this purpose, a Support Vector Machine (SVM) was trained in a nested 5-fold cross-validation scheme, by exploiting several unsupervised feature selection methods. The predictive model performance was evaluated in terms of Area Under the Receiver Operating Characteristic (AUROC), specificity, sensitivity, PPV and NPV. The test was performed on unseen held-out data.
RESULTS: The model combining Unsupervised Discriminative Feature Selection (UDFS) and SVMs on average achieved the best performance on the blinded test set: AUROC = 0.725±0.091, sensitivity = 0.709±0.176, specificity = 0.741±0.114, PPV = 0.72±0.093, and NPV = 0.75±0.114.
CONCLUSION: In this study, we built a radiomic predictive model based on breast DCE-MRI, using only the strongest enhancement phase, with promising results in terms of accuracy and specificity in the differentiation of malignant from benign breast lesions.
引用
- Militello C, Rundo L, Dimarco M, et al. 3D DCE-MRI Radiomic Analysis for Malignant Lesion Prediction in Breast Cancer Patients. Acad Radiol. 2021. PMID: 34600805. doi:10.1016/j.acra.2021.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。